bug-parted post from address@hidden requires approval

[bug-parted-owner]

As list administrator, your authorization is requested for the
following mailing list posting:

    List:    address@hidden
    From:    address@hidden
    Subject: pumpkin messenger
    Reason:  Post by non-member to a members-only list

At your convenience, visit:

    http://lists.gnu.org/mailman/admindb/bug-parted
        
to approve or deny the request.
> --- Begin Message ---
>
>
>
> Subject: 
>
> pumpkin messenger
>
>
>
>
> Date: 
>
> Fri, 6 Jul 2007 00:31:48 -0500
>
>
>
>
> User-agent: 
>
> Thunderbird 1.5.0.12 (Windows/20070509)
>
>
>
>
> Brokers Move On ERMX!
>
> EntreMetrix Inc. (ERMX)
> $0.18
>
> Heavy trading today as ERMX announced its launch of digital support
> tools for its portfolio companies. Brokers are getting ahead of this
> steady climb as they grab up large blocks of shares for there clients.
> Look at the numbers and get on ERMX Friday morning!
>
> com           Internet platform for research antibodies - search and
> order. Discovery Partners              Technology development and
> discovery research services.
> Clintrac International               A Contract Research Organization
> located in Bangalore, India. CimQuest     Computer systems validation
> consulting. BIOTECH Patent News       Monthly newsletter that publishes
> information about the patenting and licensing of biotechnology research.
> FDAWeb         FDA news updated many times a day. Biotech Insight     
> Stock letter for biotech investors.
>
> topac           Distributor of a broad range of scientific, industrial
> and process control instrumentation. Cell Therapies     CRO for clinical
> trials involving cell and tissue manipulation.
>
> Anderson's Timesaving Comparative Guides             Reference for life
> science researchers, providing a comprehensive catalog of enzymes,
> chemicals, commercial libraries, and more. Comgenex Direct            
> Products and services for high throughput and drug discovery programs.
> Aagami Lifescience Catalyst  CRO - custom syntheis of speciality
> chemicals; pre-clinical studies, in silico, in vitro and in vivo;
> clinical trials.
>
>
>
>
> --- End Message ---
> --- Begin Message ---
>
>
>
> Subject: 
>
> confirm d18ca37be1a081070795f6b03db74aef58170978
>
>
>
>
> If you reply to this message, keeping the Subject: header intact,
> Mailman will discard the held message.  Do this if the message is
> spam.  If you reply to this message and include an Approved: header
> with the list password in it, the message will be approved for posting
> to the list.  The Approved: header can also appear in the first line
> of the body of the reply.
>
> --- End Message ---